About Benjamin McGraw
Benjamin McGraw is a director at Evommune.
Benjamin McGraw reports to the SEC as a director or officer of 4 public companies, including Aerie Pharmaceuticals (AERI), Ista Pharmaceuticals (ISTA) and Urigen Pharmaceuticals (URGP).
Benjamin McGraw first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin McGraw in the role, so the role may have started earlier or lasted longer.
AI
Aerie Pharmaceuticals Inc.
Interim Executive Chair
2014 – 2022 · Public company (AERI)
II
Ista Pharmaceuticals Inc.
Director
2006 – 2012 · Public company (ISTA)
UI
Urigen Pharmaceuticals, Inc.
COB, President and CEO, director
2006 – 2007 · Public company (URGP)
Key Colleagues at Startups
The people Benjamin McGraw works with at each company, as listed on that company's latest Form D.
Evommune, Inc. · Form D, Jan 8, 2025
JD
Janice Drew
Executive officer
DC
David Cohen
Director
RH
Robert Hopfner
Director
DD
Derek DiRocco
Director
GM
Gregory Moss
Chief Business and Legal Officer
EB
Eugene Bauer
Executive officer and director
FW
Felice Verduyn-van Weegen
Director
FB
Francois Beaubien
Director
JP
Jeegar Patel
Executive officer
YY
Yuexin Yu
Director
LP
Luis Pena
Executive officer and director
KC
Kyle Carver
Executive officer